非酒精性脂肪性肝病与新发慢性肾脏病风险:更新版荟萃分析
OBJECTIVE: Studies reported a significant association between non-alcoholic fatty liver disease (NAFLD) and increased risk of chronic kidney disease (CKD). However, whether this risk changes with increasing severity of NAFLD remains uncertain.…
要点
- NAFLD患者新发CKD≥3期风险约升高1.45倍(HR 1.43,95%CI 1.33–1.54)。
- 该关联独立于年龄、性别、肥胖、高血压、糖尿病等传统CKD危险因素。
- NAFLD严重程度与新发CKD风险的关系尚需进一步研究。
核心结论
- NAFLD与新发CKD≥3期的长期风险显著相关,约升高1.45倍。
- NAFLD严重程度与新发CKD风险的关联仍需进一步研究。
研究设计与样本
- 系统检索PubMed、Web of Science和Scopus(2000年1月至2020年8月)的观察性研究,随访≥1年。
- NAFLD诊断依据血液生物标志物/评分、ICD编码、影像学或活检;采用随机效应模型进行荟萃分析。
主要发现
- NAFLD与新发CKD风险中度升高相关(n=10项研究;随机效应HR 1.43,95%CI 1.33–1.54;I2=60.7%)。
- 所有风险均独立于年龄、性别、肥胖、高血压、糖尿病及其他传统CKD危险因素。
- 敏感性分析未改变上述发现;漏斗图未显示显著发表偏倚。
关键数值与推荐
- CKD≥3期定义为估算肾小球滤过率<60 mL/min/1.73 m2,伴或不伴明显蛋白尿。
- NAFLD与新发CKD关联的随机效应HR为1.43(95%CI 1.33–1.54),I2=60.7%。
临床怎么用
- 对NAFLD患者应关注新发CKD≥3期的长期风险,考虑定期监测肾功能。
- 该关联独立于传统CKD危险因素,提示NAFLD本身可能是CKD风险标志。
局限性
- NAFLD严重程度与新发CKD风险的关联尚未明确,需进一步研究。
- 纳入研究间存在中度异质性(I2=60.7%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Studies reported a significant association between non-alcoholic fatty liver disease (NAFLD) and increased risk of chronic kidney disease (CKD). However, whether this risk changes with increasing severity of NAFLD remains uncertain. We performed a meta-analysis of observational studies to quantify the magnitude of the association between NAFLD and risk of incident CKD. DESIGN: We systematically searched PubMed, Web of Science and Scopus from January 2000 to August 2020 using predefined keywords to identify observational studies with a follow-up duration of ≥1 year, in which NAFLD was diagnosed by blood biomarkers/scores, International Classification of Diseases codes, imaging techniques or biopsy. Data from selected studies were extracted, and meta-analysis was performed using random-effects modelling. RESULTS: 13 studies with 1 222 032 individuals (28.1% with NAFLD) and 33 840 cases of incident CKD stage ≥3 (defined as estimated glomerular filtration rate <60 mL/min/1.73 m2, with or without accompanying overt proteinuria) over a median follow-up of 9.7 years were included. NAFLD was associated with a moderately increased risk of incident CKD (n=10 studies; random-effects HR 1.43, 95% CI 1.33 to 1.54; I2 =60.7%). All risks were independent of age, sex, obesity, hypertension, diabetes and other conventional CKD risk factors. Sensitivity analyses did not alter these findings. Funnel plot did not reveal any significant publication bias. CONCLUSION: This large and updated meta-analysis indicates that NAFLD is significantly associated with a~1.45-fold increased long-term risk of incident CKD stage ≥3. Further studies are needed to examine the association between the severity of NAFLD and risk of incident CKD.
引用
- Mantovani A, Petracca G, Beatrice G, et al. Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis. Gut. 2020. PMID: 33303564. doi:10.1136/gutjnl-2020-323082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。